Neurons under viral attack: victims or warriors?
When the central nervous system (CNS) is under viral attack, defensive antiviral responses must necessarily arise from the CNS itself to rapidly and efficiently curb infections with minimal collateral damage to the sensitive, specialized and non-regenerating neural tissue. This presents a unique challenge because an intact blood-brain barrier (BBB) and lack of proper lymphatic drainage keeps the CNS virtually outside the radar of circulating immune cells that are at constant vigilance for antigens in peripheral tissues. Limited antigen presentation skills of CNS cells in comparison to peripheral tissues is because of a total lack of dendritic cells and feeble expression of major histocompatibility complex (MHC) proteins in neurons and glia. However, research over the past two decades has identified immune effector mechanisms intrinsic to the CNS for immediate tackling, attenuating and clearing of viral infections, with assistance pouring in from peripheral circulation in the form of neutralizing antibodies and cytotoxic T cells at a later stage. Specialized CNS cells, microglia and astrocytes, were regarded as sole sentinels of the brain for containing a viral onslaught but neurons held little recognition as a potential candidate for protecting itself from the proliferation and pathogenesis of neurotropic viruses. Accumulating evidence however indicates that extracellular insult causes neurons to express immune factors characteristic of lymphoid tissues. This article aims to comprehensively analyze current research on this conditional alteration in the protein expression repertoire of neurons and the role it plays in CNS innate immune response to counter viral infections.
Chakraborty
Swarupa
S
National Brain Research Centre, Manesar, Haryana, India.
Nazmi
Arshed
A
Dutta
Kallol
K
Basu
Anirban
A
D056704:Adaptive Immunity; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents; D002493:Central Nervous System Diseases / Q000276:immunology* / Q000821:virology*; D016207:Cytokines / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D007109:Immunity / Q000235:genetics; D007371:Interferon-gamma / Q000502:physiology; D008285:Major Histocompatibility Complex / Q000276:immunology; D020782:Matrix Metalloproteinases / Q000235:genetics; D009457:Neuroglia / Q000276:immunology; D009474:Neurons / Q000276:immunology* / Q000821:virology*; D013601:T-Lymphocytes / Q000276:immunology; D051193:Toll-Like Receptors; D014777:Virus Diseases / Q000276:immunology*
D000956:Antigens, Viral; D000998:Antiviral Agents; D016207:Cytokines; D051193:Toll-Like Receptors; D007371:Interferon-gamma; D020782:Matrix Metalloproteinases